Amsterdam, Netherlands

Joost Huibert Van Den Berg

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Joost Huibert Van Den Berg

Introduction: Joost Huibert Van Den Berg is a notable inventor based in Amsterdam, NL. He has made significant contributions to the field of immunotherapy, particularly through his research and innovations in T cell manufacturing. With his dedication to advancing cancer treatment, he holds a patent that showcases his expertise and vision.

Latest Patents: Joost's patent, titled "T cell manufacturing compositions and methods," focuses on the generation of antigen-specific T cells through controlled ex vivo induction or expansion. This method presents a promising avenue for highly specific and beneficial T cell therapies aimed at treating cancer and various other conditions. The patent emphasizes therapeutic T cell compositions that can fundamentally change how personalized antigen-specific T cell therapy is conducted.

Career Highlights: Throughout his career, Joost has contributed to important research initiatives in various institutions. He has worked at BioNTech US Inc., a company recognized for its groundbreaking work in immunotherapy, and Stichting Het Nederlands Kanker Instituut—Antoni van Leeuwenhoek Ziekenhuis, where he focused on cancer research and treatment.

Collaborations: Joost has collaborated with several talented individuals in his field, including Marit M Van Buuren and Divya Reddy Lenkala. Their joint efforts have further advanced the understanding and application of T cell therapies.

Conclusion: Joost Huibert Van Den Berg's contributions to the field of T cell manufacturing highlight his innovative spirit and dedication to improving cancer treatments. His patent serves as a testament to his capability as an inventor and his commitment to helping patients through advancements in T cell therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…